COSCIENS Biopharma Inc. Common Stock
CSCI
CSCI was delisted on the 3rd of September, 2025.
17 hedge funds and large institutions have $5.46M invested in COSCIENS Biopharma Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 9 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
256% more capital invested
Capital invested by funds: $1.53M → $5.46M (+$3.93M)
11% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 9
6% more funds holding
Funds holding: 16 → 17 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$3.35M |
| 2 |
Renaissance Technologies
New York
|
+$2.35M |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$824K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$143K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$72.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tenor Capital Management
New York
|
-$288K |
| 2 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$119K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$58K |
| 4 |
Two Sigma Investments
New York
|
-$14K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
-$6.91K |
CSCI Hedge Fund Activity: Q4 2015 in Review
17 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in COSCIENS Biopharma Inc. Common Stock (CSCI) for Q4 2015, worth a combined $5.46M — up 256% from $1.53M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new CSCI positions and 9 closed out — a net gain of 1 holder — while 5 added to existing stakes and 1 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $3.35M. The largest seller was Tenor Capital Management, exiting entirely with an estimated $288K sold.
- 17 institutional investors held COSCIENS Biopharma Inc. Common Stock (CSCI) as of Q4 2015, up from 16 in Q3 2015.
- Funds reported $5.46M of COSCIENS Biopharma Inc. Common Stock stock for Q4 2015, up 256% quarter-over-quarter.
- 10 funds opened new COSCIENS Biopharma Inc. Common Stock positions in Q4 2015 and 9 closed out, a net change of +1 holder.
- The largest COSCIENS Biopharma Inc. Common Stock buyer in Q4 2015 was Sabby Management, an estimated $3.35M added.
- The largest COSCIENS Biopharma Inc. Common Stock seller in Q4 2015 was Tenor Capital Management, an estimated $288K sold.
Based on aggregated 13F filings for Q4 2015.